Literature DB >> 27394435

Myocardial blood volume reserve by intravenous contrast echocardiography predicts improvement in left ventricular function in patients with nonischemic dilated cardiomyopathy.

Yoko Miyata-Fukuoka1, Hiroya Kawai2,3, Osamu Iseki1, Yoshio Yamanaka1, Yoshiaki Ueda1, Mitsuhiro Yokoyama4, Ken-Ichi Hirata1.   

Abstract

BACKGROUND: Impaired myocardial perfusion has been shown in nonischemic dilated cardiomyopathy (DCM). Intravenous myocardial contrast echocardiography (MCE) has been introduced to examine myocardial blood volume (MBV) noninvasively. This study was designed to evaluate if MBV reserve assessed by intravenous MCE with adenosine triphosphate (ATP) can predict efficacy of optimal medical therapy in patients with DCM. METHODS AND
RESULTS: Fifteen DCM patients and 8 control subjects underwent conventional echocardiography and intravenous MCE. We obtained the change in peak contrast integrated backscatter intensity (∆PI) by ATP on the left ventricular (LV) anteroseptal myocardium. After 3 months of optimal medical therapy in DCM patients, we reperformed conventional echocardiography. A good responder to therapy was defined as a decrease in LVDd >5 mm to final LVDd <55 mm and increase in LVEF >20 % to final LVEF >45 %. In DCM patients, ∆PI was lower compared to controls (p < 0.001). Good responders to therapy (n = 6) had higher ∆PI than poor responders (n = 9) (p < 0.05).
CONCLUSIONS: The present study demonstrates that the response to the medical therapy in DCM is predicted by the assessment of dilator reserve in MBV. Intravenous MCE with ATP may provide useful information to evaluate MBV reserve.

Entities:  

Keywords:  Efficacy of medical therapy; Intravenous myocardial contrast echocardiography; Myocardial blood volume reserve; Nonischemic dilated cardiomyopathy

Mesh:

Year:  2016        PMID: 27394435     DOI: 10.1007/s12574-016-0302-8

Source DB:  PubMed          Journal:  J Echocardiogr        ISSN: 1349-0222


  28 in total

1.  Potential pitfalls of visualization of myocardial perfusion by myocardial contrast echocardiography with harmonic gray scale B-mode and power Doppler imaging.

Authors:  Hisashi Masugata; Kazushi Yukiiri; Yuichiro Takagi; Koji Ohmori; Katsufumi Mizushige; Masakazu Kohno
Journal:  Int J Cardiovasc Imaging       Date:  2004-04       Impact factor: 2.357

2.  Novel quantitative assessment of myocardial perfusion by harmonic power Doppler imaging during myocardial contrast echocardiography.

Authors:  S Yamada; K Komuro; T Mikami; N Kudo; H Onozuka; K Goto; S Fujii; K Yamamoto; A Kitabatake
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

3.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion.

Authors:  K Wei; A R Jayaweera; S Firoozan; A Linka; D M Skyba; S Kaul
Journal:  Circulation       Date:  1998-02-10       Impact factor: 29.690

4.  Prevalence, predictors, and prognosis of reversal of maladaptive remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy.

Authors:  K Kawai; H Takaoka; K Hata; Y Yokota; M Yokoyama
Journal:  Am J Cardiol       Date:  1999-09-15       Impact factor: 2.778

5.  Differential coronary microvascular function in patients with left ventricular dysfunction of unknown cause--implication for possible mechanism of myocardial ischemia in early stage of cardiomyopathy.

Authors:  J W Chen; C T Ting; Y H Chen; T C Wu; N W Hsu; S J Lin; M S Chang
Journal:  Int J Cardiol       Date:  1999-06-01       Impact factor: 4.164

6.  Ischemia-reperfusion injury at the microvascular level: treatment by endothelin A-selective antagonist and evaluation by myocardial contrast echocardiography.

Authors:  L Galiuto; A N DeMaria; U del Balzo; K May-Newman; S F Flaim; P L Wolf; M Kirchengast; S Iliceto
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

7.  Coronary vasodilatory capacity is impaired in patients with dilated cardiomyopathy.

Authors:  S Weismüller; J Czernin; K T Sun; C Fung; M E Phelps; H R Schelbert
Journal:  Am J Card Imaging       Date:  1996-07

8.  Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint.

Authors:  T Yamada; M Fukunami; M Ohmori; K Iwakura; K Kumagai; N Kondoh; T Minamino; E Tsujimura; T Nagareda; K Kotoh
Journal:  J Am Coll Cardiol       Date:  1993-03-01       Impact factor: 24.094

9.  Coronary flow reserve in patients with dilated cardiomyopathy.

Authors:  T Inoue; Y Sakai; S Morooka; T Hayashi; K Takayanagi; T Yamanaka; H Kakoi; Y Takabatake
Journal:  Am Heart J       Date:  1993-01       Impact factor: 4.749

10.  Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy.

Authors:  C B Treasure; J A Vita; D A Cox; R D Fish; J B Gordon; G H Mudge; W S Colucci; M G Sutton; A P Selwyn; R W Alexander
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

View more
  1 in total

1.  Added value of contrast echocardiography in characterization of nonischemic cardiomyopathy.

Authors:  Shufang Pi; Yingwu Liu; Tong Li; Wenjin Peng; Dong Wang; Lei Huang; Ningdong Kang
Journal:  J Int Med Res       Date:  2018-09-13       Impact factor: 1.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.